Home Nav
Nextech Invest Logo

Alfred Scheidegger

Alfred Scheidegger

Prior to founding Nextech Venture AG (today Nextech Invest AG) in 1998, Dr Scheidegger was managing director and board member of the Swiss Federal Institute of Technology (ETH) Zurich, Switzerland. He has held previous roles as the managing director of the Swiss Supercomputing Center (CSCS) and directed an international drug-discovery project at Ciba-Geigy (today Novartis), Japan. In 1998, he was involved in launching the first Swiss national business plan competition, venture97. Dr Scheidegger holds a PhD in microbiology and biochemistry from the University of Basel, Switzerland and did his postdoctoral research training in enzymology at the University of Kyoto, Japan. Dr Scheidegger completed an executive training program (TGM) at Harvard Business School, USA.   Currently, Alfred Scheidegger is on the board of directors at Cleave Biosciences, Molecular MD (observer), Dottikon ES Holding, and Rising Tide Foundation. Past board representations include Agensys (acquired by Astellas), Ganymed Pharmaceuticals (acquired by ATS), MacroGenics (NASDAQ: MGNX), Sunesis Pharmaceuticals (NASDAQ: SNSS), TetraLogic Pharmaceuticals (NASDAQ: TLOG), and Tracon Pharmaceuticals (NASDAQ: TCON).

Mr. Scheidegger is responsible for the following Nextech portfolio companies:

Tracon Pharmaceuticals, MolecularMD, Cleave Biosciences

Portfolio companies Mr. Scheidegger has been involved with previously:

TetraLogic Pharmaceuticals, TeLoRmedix, Sunesis Pharmaceuticals, Palyon Medical, MacroGenics, Ganymed Pharmaceuticals, Agensys

 

59th ASH Annual Meeting

09.12. – 12.12.2017

Atlanta, USA

  • 13.11.2017

    Jounce Therapeutics reports third quarter 2017 financial...

  • 13.11.2017

    Tracon Pharmaceuticals announces positive results from...

  • 10.11.2017

    Blueprint Medicines announces new data from ongoing...

Close

Newsletter Registration

Please fill in the subscription form completely. If you wish to modify your personal data or to change/cancel your newsletter subscription, this is possible at any time.

A link to your subscription profile can be found in every newsletter email.

Preview

* Compulsory fields

Close

Newsletter Registration

Your eMail have been successfully registered.

Close